Developers of innovative drug products dealing with protein formulations, nucleotide-based drugs, peptides, and poorly soluble molecules, face significant challenges in achieving efficient and scalable manufacturing solutions.
Developers of innovative drug products dealing with protein formulations, nucleotide-based drugs, peptides, and poorly soluble molecules, face significant challenges in achieving efficient and scalable manufacturing solutions.
Summary: This insightful webinar explores the latest innovations in pregastric absorption. Learn more about advancements in buccal and sublingual delivery systems, the impact of permeation enhancers, and the role of PBPK modeling in predictive formulation design…
Summary: In a Fireside Chat during the 2025 J.P. Morgan Healthcare Conference, Catalent President & CEO Alessandro Maselli shared his predictions for 2025, and his thoughts on the top risks and opportunities in Biotech.
In this webinar, participants will learn about a comprehensive strategy to streamline development and derisk clinical studies. Experts will focus on the importance of physiologically based pharmacokinetic (PBPK) modeling, formulation, and technology expertise while sparing API and managing funding and timeline challenges.
